2022 DRUG TREND REPORT
Our business
is personal
Transforming Access To Pharmacy Benefits
Medications play a vital role in people's lives. They can be lifesaving and life changing. However, many Americans struggle with the cost of prescription drugs. At Navitus, this is personal to us.
We exist to make medications more affordable for the people who need them.
At Navitus, we do what we do for the right reasons: to help members afford the medications they need to they can live their lives more fully, and to ensure that plan sponsors and health plans have full visibility into their pharmacy benefits so they can make good decisions. As a result, we:
• Do not mark up drug prices |
• Do not take spread |
• Do not keep a portion of the rebates |
• Believe customers own their data |
This year’s report highlights our ability to transform pharmacy benefits, keep costs well-managed and make sure that people get the care they need.
I invite you to explore the results that Navitus delivered in 2022.
Brent Eberle
Chief Pharmacy Officer, Navitus Health Solutions
49% of navitus commercial clients had a negative cost trend compared to 2021
This was primarily achieved by:
- Improved pharmacy network rates and increased rebates and manufacturer fees
- Appropriate formulary and utilization management
1 Net total cost paid by plans and members minus manufacturer rebates
Total Net Cost PMPM
Specialty medications accounted for over 50% of total spend for Navitus' commercial book of business, despite only representing about 1% of overall utilization.
How Navitus
does it
- Only bills clients what Navitus pays pharmacies
- Passes through 100% of network discounts and rebates received
- Drives purchasing efficiencies to control costs
- Prioritizes clinically appropriate care that supports outcomes
- Recommends generic over brand drugs when appropriate
Additionally, plans that took advantage of a limited pharmacy network that included Costco's 90-day option saved an additional 3-5% on prescriptions filled at local pharmacies
GET THE 2022 DRUG TREND EXECUTIVE SUMMARY
Download your free copy
Methodology
The Navitus drug trend is calculated by comparing the net total cost PMPM for 2022 to that for 2021. Net cost PMPM represents full-year (Q1-Q4) data for total member copays and plan paid amounts minus manufacturer rebates and fees. The value is divided by the total number of members and by 12 months of the year.
Net total cost PMPM trend consists of two components: utilization and cost and includes both specialty and non-specialty drugs. Utlization trend measures the change in total days of therapy. Cost trend measures the change in net total drug cost per the above. This analysis included data for more than 500 clients, representing 2.2M members within Navitus' commercial book of business, including plan sponsors and health plans. To be included, these organizations must have been clients of Navitus in both 2021 and 2022. Exclusions from this analysis include products administered at physicians' offices, clinics and hospitals, COVID-19 vaccines and supplies and any additional savings from copay assistance programs.